| KOMISJA NADZORU FINANSOWEGO | |||||||||||
| Raport bieżący nr | 26 | / | 2020 | ||||||||
| Data sporządzenia: | 2020-11-04 | ||||||||||
| Skrócona nazwa emitenta | |||||||||||
| MILESTONE MEDICAL | |||||||||||
| Temat | |||||||||||
| Resolutions adopted by Annual General Meeting of Shareholders on November 4, 2020 - revision to ESPI 25/2020 | |||||||||||
| Podstawa prawna | |||||||||||
| Inne uregulowania | |||||||||||
| Treść raportu: | |||||||||||
| The Board of Directors of Milestone Medical Inc. (“the Company”, ‘the Issuer”) provides resolutions (both thr minutes and report of inspector of elections) adopted by the Annual General Meeting of Shareholders on November 4, 2020. The Board of Directors of Milestone Medical Inc. provides the revision to ESPI 25/2020, which included only the minutes from the Annual General Meeting of Shareholders on November 4, 2020 During the Annual General Meeting there were no objections to the adopted resolutions. | |||||||||||
| Załączniki | |||||||||||
| Plik | Opis | ||||||||||
| MMD Annual Meeting Resolutions November 4 2020.pdf | |||||||||||
| MESSAGE (ENGLISH VERSION) | |||
| MILESTONE MEDICAL INC | |||||||||||||
| (pełna nazwa emitenta) | |||||||||||||
| MILESTONE MEDICAL | |||||||||||||
| (skrócona nazwa emitenta) | (sektor wg. klasyfikacji GPW w W-wie) | ||||||||||||
| NJ 07039 | . | ||||||||||||
| (kod pocztowy) | (miejscowość) | ||||||||||||
| South Orange Avenue Livingston | 220 | ||||||||||||
| (ulica) | (numer) | ||||||||||||
| +11 973 535 2717 | +11 973 535 2829 | ||||||||||||
| (telefon) | (fax) | ||||||||||||
| (e-mail) | (www) | ||||||||||||
| 27-5484393 | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| PODPISY OSÓB REPREZENTUJĄCYCH SPÓŁKĘ | |||||
| Data | Imię i Nazwisko | Stanowisko/Funkcja | Podpis | ||
| 2020-11-04 | Joseph D'Agostino | Chief Financial Officer | Joseph D'Agostino | ||
MMD Annual Meeting Resolutions November 4 2020.pdf
